BeiGene Ltd (ONC)
250.47
-2.73
(-1.08%)
USD |
NASDAQ |
Mar 25, 16:00
250.98
+0.51
(+0.20%)
After-Hours: 20:00
BeiGene Profit Margin (Quarterly): -13.47% for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Gilead Sciences Inc | 23.56% |
| Leap Therapeutics Inc | -- |
| Catalyst Pharmaceuticals Inc | 39.44% |
| Exelixis Inc | 24.68% |
| Halozyme Therapeutics Inc | 45.98% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -18.93% |
| Return on Assets | -11.14% |
| Return on Invested Capital | -14.62% |
| Gross Profit Margin (Quarterly) | 85.76% |
| Operating Margin (Quarterly) | -7.04% |
| Return on Net Operating Assets | -22.85% |